The mechanism of lovastatin in suppressing the proliferation of esophageal squamous cell carcinoma based on proteomics.
Feng PengLili ZhuJiang FanFu YangPublished in: The journal of gene medicine (2024)
These results demonstrate the huge potential of lovastatin as an RAB38, RAB27A inhibitor in esophageal cancer chemotherapy and chemoprevention.